Virbac SA (Euronext: VIRP; reference: 0NM7), the Carros, France-based veterinary pharmaceutical company, has announced it will participate in the Jefferies Global Healthcare Conference in London on Wednesday, 18 November 2026. Chief Executive Officer Paul Martingell and Group CFO and Deputy CEO Habib Ramdani will jointly deliver a company presentation and take part in a Q&A session at 4:30 p.m. GMT. The appearance gives investors and analysts a scheduled opportunity to hear directly from Virbac's senior leadership on the company's strategy and outlook within the global animal health sector.

Key Points

  • Virbac SA (Euronext: VIRP; 0NM7), headquartered in Carros, France
  • CEO Paul Martingell and CFO Habib Ramdani to present at the Jefferies Global Healthcare Conference in London
  • Presentation and Q&A scheduled for Wednesday, 18 November 2026 at 4:30 p.m. GMT; live webcast and replay available via the Virbac investor relations website
  • Investors should watch for any strategic or financial commentary emerging from the Q&A session

Virbac's CEO and CFO to Appear Jointly Before Analysts at London Healthcare Event

The announcement confirms that both of Virbac's most senior executives — Paul Martingell in his capacity as Chief Executive Officer, and Habib Ramdani as Group CFO and Deputy CEO — will appear together at the Jefferies Global Healthcare Conference. The dual presence of the CEO and CFO at a major investor-focused healthcare conference is notable, as it suggests the company is prioritising direct engagement with the institutional investment community. Virbac is a specialist in veterinary medicines and animal health products, operating internationally from its base in Carros, in the south of France.

Live Webcast Access and Replay Arrangements for the 18 November Jefferies Session

Virbac has confirmed that a live webcast of the presentation will be accessible through its investor relations section at corporate.virbac.com, specifically via the analysts and investors presentations page for 2026. Following the conclusion of the event, a replay will also be made available on the same platform, broadening access for shareholders and analysts who are unable to attend or watch the session in real time on 18 November. The company did not disclose whether a written transcript or presentation slides would be published alongside the replay.

Jefferies Global Healthcare Conference as a Platform for Animal Health Sector Dialogue

The Jefferies Global Healthcare Conference is an established forum that brings together companies across the broader healthcare and life sciences sectors with institutional investors and equity analysts. For a veterinary pharmaceutical group such as Virbac, participation alongside human healthcare peers reflects the growing convergence of animal and human health investment themes. Investors may be watching for any commentary from Martingell and Ramdani on commercial performance, product pipeline developments, or geographic expansion within the global animal health market, though no specific agenda items were disclosed in the announcement.